Type of deal: Sale of shares
Deal size: €574m
Sector: Healthcare
Terveystalo Plc has signed a share purchase agreement to acquire Silmäasema Oy, the leading vision and eye health company in Finland, for approximately €574 million, the companies announced Monday. The transaction combines Terveystalo’s healthcare services with Silmäasema’s integrated eye care and optical retail network, creating a market leader in Finland’s growing eye care market. The combined company would serve about 2 million customers annually and generate approximately €1.55 billion in revenue based on 2025 financial figures. Under the agreement, Terveystalo will pay an initial cash payment of €275 million and issue 36.5 million new shares valued at €8.20 per share, based on the company’s closing price June 5. Upon completion, Coronaria Oy, Silmäasema’s main seller alongside institutional shareholders and management, will become Terveystalo’s largest shareholder with approximately 15.1% of outstanding shares and voting rights.
Object of sale: Silmäasema Oy
Seller: Coronaria Oy
Buyer: Terveystalo Oyj
Deal announcement date: 8 June 2026
PwC's role: We supported Coronaria Oy through the provision of due diligence services, comprising financial and tax due diligence on Terveystalo Oyj, in connection with the sale of Silmäasema Oy.
Miika Liisanantti
Heikki Lajunen